C4 Therapeutics (CCCC) stock, explained like you're 5

Is C4 Therapeutics a small, medium or large cap company?

No. C4 Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 389 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How C4 Therapeutics makes money

• Selling medicines, medical devices or healthcare services.
• Insurance premiums or hospital and clinic fees.
• Research and licensing deals.

What moves CCCC stock

• Results from clinical trials and approvals from regulators.
• Drug prices, insurance rules and government policy.
• Patents running out and new competing treatments.

In the news lately

• In two patients with blood cancer, tests suggest a drug combo may keep immune cells from wearing out. (Stock Titan)
• Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year? (Yahoo Finance)
• JPMorgan initiates C4 Therapeutics stock coverage at Overweight (Investing.com)
• CCCC Stock Reverses Pre Market Gains After Roche Tie Up To Develop Cancer Treatments Retail Sees Strong Upside (Stocktwits)
• Earnings Beat: C4 Therapeutics, Inc. (NASDAQ:CCCC) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts (Simply Wall Street)

Key terms to know before you follow CCCC

• Market cap
• P/E ratio
• EPS (earnings per share)
• Earnings report
• Volatility